Invention Grant
US08007995B2 Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers
有权
Moesin，小窝蛋白1和是相关蛋白1作为乳腺癌中达沙替尼的预测指标
- Patent Title: Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers
- Patent Title (中): Moesin，小窝蛋白1和是相关蛋白1作为乳腺癌中达沙替尼的预测指标
-
Application No.: US12093042Application Date: 2006-11-10
-
Publication No.: US08007995B2Publication Date: 2011-08-30
- Inventor: Richard S. Finn , Judy Dering , Dennis J. Slamon , Charles L. Ginther , Edwin A. Clark
- Applicant: Richard S. Finn , Judy Dering , Dennis J. Slamon , Charles L. Ginther , Edwin A. Clark
- Applicant Address: US NJ Princeton US CA Oakland
- Assignee: Bristol-Myers Squibb Company,The Regents of the University of California
- Current Assignee: Bristol-Myers Squibb Company,The Regents of the University of California
- Current Assignee Address: US NJ Princeton US CA Oakland
- Agency: Woodcock Washburn LLP
- International Application: PCT/US2006/060776 WO 20061110
- International Announcement: WO2007/059430 WO 20070524
- Main IPC: C12Q1/00
- IPC: C12Q1/00 ; C12Q1/68 ; G01N33/53 ; G01N33/574
Abstract:
The invention described herein relates to methods and compositions useful in the diagnosis, treatment and management of cancers that express particular genes, including the moesin, caveolin 1, and/or yes-associated protein 1 genes.
Public/Granted literature
Information query
